Ligand validation:6HG5

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6HG5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HG5_NAG_A_501	64%	31%	0.11	0.909	1.29	1.44	1	2	0	0	100%	0.9333
6HG5_NAG_C_501	28%	22%	0.196	0.85	1.32	1.88	3	4	2	0	100%	0.9333
6HG5_NAG_D_501	1%	14%	0.277	0.494	2.01	1.83	4	6	1	0	100%	0.9333
6HFY_NAG_C_501	72%	20%	0.114	0.939	1.15	2.22	2	5	0	0	100%	0.9333
1V0Z_NAG_C_506	63%	54%	0.127	0.933	0.67	1.11	-	1	5	0	93%	0.9333
5HUM_NAG_A_503	61%	62%	0.109	0.898	0.8	0.66	1	-	0	0	100%	0.9333
1W1X_NAG_A_1485	55%	66%	0.137	0.905	0.27	1.01	-	1	2	0	100%	0.9333
2CML_NAG_B_2480	51%	7%	0.164	0.918	2.31	2.53	1	6	5	1	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.